the report was compiled by outside researchers who went into the fda�s own database of �serious adverse [medical-drug] events.�
.
the youngest claimant was aged 20, and the eldest aged 89, while the average policy duration at claim stage was 10 years.
.
.
.
. "the importance of our new method is that it allows for precise and automated measurement of the disease," bentley added in the study published in the journal radiology.
.
andrew kaye, head of policy at macmillan cancer support said it was �shocking� that a cancer patient had to wait 541 days for treatment.